Skip to main content

Advertisement

Log in

Effect of prolonged expressive writing on health outcomes in breast cancer patients receiving chemotherapy: a multicenter randomized controlled trial

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

This study aims to evaluate the effects of prolonged expressive writing on health outcomes in breast cancer patients undergoing chemotherapy to help understand how the dosage of an expressive writing intervention might moderate its effects.

Methods

A total of 112 breast cancer patients undergoing chemotherapy were randomly allocated to the expressive writing group (n = 56) or the prolonged expressive writing group (n = 56). The expressive writing group received the standard expressive writing intervention based on Pennebaker’s prompt to write for at least 20 min over four consecutive days (4 sessions). The prolonged expressive writing group used a modified prompt: write for at least 20 min 3 times a week over a 4-week period (12 sessions); patients could choose whether to write on consecutive days or not. All participants were required to write about their stressor-related upsetting or traumatic feelings about breast cancer. Outcomes were assessed and compared at baseline, as well as 1 month, 3 months, and 6 months postintervention.

Results

There was no significant difference in the patients’ quality of life, or physical and psychological wellbeing between the expressive writing group and the prolonged expressive writing group at any time point (all p > .05). The quality of life of breast cancer patients significantly decreased in the two groups over time (F = 40.64, p < .001).

Conclusion

Our findings suggest that the writing dosage does not moderate the effects of expressive writing on breast cancer patients undergoing chemotherapy.

Trial registration

ChiCTR1800016278

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The corresponding author has full control of all primary data. Primary data are available on request.

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386

    PubMed  CAS  Google Scholar 

  2. Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M (2013) Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months. Psycho-Oncology 22(9):2071–2078

    PubMed  Google Scholar 

  3. Plummer L, Chalmers K (2016) Health literacy and physical activity in women diagnosed with breast cancer. Psycho-Oncology 11:1–6

    Google Scholar 

  4. Hennigs A, Riedel F, Marmé F, Sinn P, Lindel K, Gondos A, Smetanay K, Golatta M, Sohn C, Schuetz F, Heil J, Schneeweiss A (2016) Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade. Breast Cancer Res Treat 160(3):491–499

    PubMed  PubMed Central  CAS  Google Scholar 

  5. Mohamady HM, Elsisi HF, Aneis YM (2017) Impact of moderate intensity aerobic exercise on chemotherapy-induced anemia in elderly women with breast cancer: a randomized controlled clinical trial. J Adv Res 8(1):7–12

    PubMed  CAS  Google Scholar 

  6. Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288–300

    PubMed  CAS  Google Scholar 

  7. Schlatter MC, Cameron LD (2010) Emotional suppression tendencies as predictors of symptoms, mood, and coping appraisals during AC chemotherapy for breast cancer treatment. Ann Behav Med 40(1):15–29

    PubMed  Google Scholar 

  8. Lally RM, Kupzyk KA, Bellavia G, Hydeman J, Gallo S, Helgeson VS, Erwin D, Mills AC, Brown JK (2020) CaringGuidance after breast cancer diagnosis eHealth psychoeducational intervention to reduce early post-diagnosis distress. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer 28(5):2163–2174

  9. Pennebaker JW, Beall SK (1986) Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol 95(3):274–281

    PubMed  CAS  Google Scholar 

  10. Corum M, Cash T, Lageman S (2014) Effect of expressive writing on the cortisol awakening response in individuals with Parkinson’s disease and their caregivers. Psychophysiology 51:S20–S20

    Google Scholar 

  11. Smith HE, Jones CJ, Hankins M, Field A, Theadom A, Bowskill R, Horne R, Frew AJ (2015) The effects of expressive writing on lung function, quality of life, medication use, and symptoms in adults with asthma: a randomized controlled trial. Psychosom Med 77(4):429–437

    PubMed  CAS  Google Scholar 

  12. Ames SC, Patten CA, Offord KP, Pennebaker JW, Croghan IT, Tri DM, Stevens SR, Hurt RD (2005) Expressive writing intervention for young adult cigarette smokers. J Clin Psychol 61(12):1555–1570

    PubMed  Google Scholar 

  13. Walker BL, Nail LM, Croyle RT (1999) Does emotional expression make a difference in reactions to breast cancer? Oncol Nurs Forum 26(6):1025–1032

    PubMed  CAS  Google Scholar 

  14. Jensen-Johansen MB, Christensen S, Valdimarsdottir H, Zakowski S, Jensen AB, Bovbjerg DH, Zachariae R (2013) Effects of an expressive writing intervention on cancer-related distress in Danish breast cancer survivors-results from a nationwide randomized clinical trial. Psychooncology 22(7):1492–1500

    PubMed  CAS  Google Scholar 

  15. Mosher CE, Duhamel KN, Lam J, Dickler M, Li Y, Massie MJ, Norton L (2012) Randomised trial of expressive writing for distressed metastatic breast cancer patients. Psychol Health 27(1):88–100

    PubMed  Google Scholar 

  16. Sohl SJ, Dietrich MS, Wallston KA, Ridner SH (2017) A randomized controlled trial of expressive writing in breast cancer survivors with lymphedema. Psychol Health 32(7):826–842

    PubMed  PubMed Central  Google Scholar 

  17. Lu Q, Dong L, Wu IHC, You J, Huang J, Hu Y (2019) The impact of an expressive writing intervention on quality of life among Chinese breast cancer patients undergoing chemotherapy. Support Care Cancer 27(1):165–173

    PubMed  Google Scholar 

  18. Mogk C et al (2006) Health effects of expressive writing on stressful or traumatic experiences-a meta-analysis. Psychosoc Med 3:1–9

    Google Scholar 

  19. Harris AH (2006) Does expressive writing reduce health care utilization? A meta-analysis of randomized trials. J Consult Clin Psychol 74(2):243–252

    PubMed  Google Scholar 

  20. Frattaroli J (2006) Experimental disclosure and its moderators: a meta-analysis. Psychol Bull 132(6):823–865

    PubMed  Google Scholar 

  21. Zachariae R, O’ Toole MS (2015) The effect of expressive writing intervention on psychological and physical health outcomes in cancer patients—a systematic review and meta-analysis. Psycho-Oncology 24(11):1349–1359

    PubMed  PubMed Central  Google Scholar 

  22. Zhou C, Wu Y, An S, Li X (2015) Effect of expressive writing intervention on health outcomes in breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. PLoS One 10(7):e0131802

    PubMed  PubMed Central  Google Scholar 

  23. Goedendorp MM, Andrykowski MA, Donovan KA, Jim HS, Phillips KM, Small BJ, Laronga C, Jacobsen PB (2012) Prolonged impact of chemotherapy on fatigue in breast cancer survivors. Cancer 118(15):3833–3841

    PubMed  Google Scholar 

  24. van der Kloot WA et al (2016) The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer. Chin Clin Oncol 5(1):3

    PubMed  Google Scholar 

  25. Craft MA, Davis GC, Paulson RM (2012) Expressive writing in early breast cancer survivors. J Adv Nurs 69(2):305–315

    PubMed  Google Scholar 

  26. Gellaitry G, Peters K, Bloomfield D, Horne R (2010) Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer. Psychooncology 19(1):77–84

    PubMed  Google Scholar 

  27. Stanton AL (2002) Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J Clin Oncol 20(20):4160–4168

    PubMed  Google Scholar 

  28. Portney LG (2009) In: Watkins MP (ed) Foundations of clinical research: applications to practice. Pearson Prentice Hall, London

    Google Scholar 

  29. Kendall J (2003) Designing a research project: randomised controlled trials and their principles. Emerg Med J 20(2):164–168

    PubMed  PubMed Central  CAS  Google Scholar 

  30. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15(3):974–986

    PubMed  CAS  Google Scholar 

  31. Wen C, Lu Q, Ding Y, Pang D, Yu X, Yang P, Jin S, Cui Q, Ying S (2012) Development and psychometric testing of the symptoms assessment inventory for breast cancer patients receiving chemotherapy. Chin J Nurs 47(5):3

  32. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370

    PubMed  CAS  Google Scholar 

  33. Park EY, Yi M (2012) Development and effectiveness of expressive writing program for women with breast cancer in Korea. J Korean Acad Nurs 42(2):269–279

    PubMed  Google Scholar 

  34. Redsell SA, Cheater FM (2001) The Data Protection Act (1998): implications for health researchers. J Adv Nurs 35(4):508–513

    PubMed  CAS  Google Scholar 

  35. World Medical Association (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194

  36. Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med 8(1):1

    Google Scholar 

  37. Gurusamy K et al (2009) Assessment of risk of bias in randomized clinical trials in surgery. Br J Surg 96(4):342–349

    PubMed  CAS  Google Scholar 

  38. Schafer JL, Graham JW (2002) Missing data: our view of the state of the art. Psychol Methods 7(2):147–177

    PubMed  Google Scholar 

  39. Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135

    PubMed  PubMed Central  Google Scholar 

  40. Howell DC (2013) Statistical methods for psychology. Wadsworth Cengage Learning, Belmont

    Google Scholar 

  41. Chan Y, Walmsley RP (1997) Learning and understanding the Kruskal-Wallis one-way analysis-of-variance-by-ranks test for differences among three or more independent groups. Phys Ther 77(12):1755–1761

    PubMed  CAS  Google Scholar 

  42. Smyth JM (1998) Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol 66(1):174–184

    PubMed  CAS  Google Scholar 

  43. Sloan DM, Marx BP (2004) Taking pen to hand: evaluating theories underlying the written disclosure paradigm. Clin Psychol Sci Pract 11(2):121–137

    Google Scholar 

  44. Polit DF (2013) In: Beck CT (ed) Essentials of nursing research: appraising evidence for nursing practice. Lippincott Williams and Wilkins, London

    Google Scholar 

  45. Henry EA, Schlegel RJ, Talley AE, Molix LA, Bettencourt BA (2010) The feasibility and effectiveness of expressive writing for rural and urban breast cancer survivors. Oncol Nurs Forum 37(6):749–757

    PubMed  Google Scholar 

  46. Low CA, Stanton AL, Danoff-Burg SK, Robert M (2006) Expressive disclosure and benefit finding among breast cancer patients: mechanisms for positive health effects. Health Psychol 25(2):181–189

    PubMed  Google Scholar 

  47. Low CA, Stanton AL, Bower JE, Gyllenhammer L (2010) A randomized controlled trial of emotionally expressive writing for women with metastatic breast cancer. Health Psychol 29(4):460–466

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We express our sincere gratitude to all the study participants and clinic staff in the five tertiary hospitals for their support with the trial. We thank Pro. Shengli An from the Department of Biostatistics from Southern Medical University for her help with the statistical analysis of the manuscript.

Funding

The study was funded by the Medical Scientific Research Foundation of Guangdong Province, China (grant number A2018090). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chunlan Zhou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent statement

The trial was approved by the involved hospitals, including the Medical Ethics Committee of Nanfang Hospital (reference number: NFEC-2018-049), The Affiliated Hospital of Guangdong Medical University (reference number: PJ2018-029), The Cancer Center of Guangzhou Medical University (reference number: 2018-003), The First Affiliated Hospital of Shantou University Medical College (reference number: 2018-039), and Shenzhen People’s Hospital (reference number: 2018-029). Written informed consent was obtained from each participant prior to the study.

Code availability

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, Y., Liu, L., Zheng, W. et al. Effect of prolonged expressive writing on health outcomes in breast cancer patients receiving chemotherapy: a multicenter randomized controlled trial. Support Care Cancer 29, 1091–1101 (2021). https://doi.org/10.1007/s00520-020-05590-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05590-y

Keywords

Navigation